Enliven Therapeutics, Inc (ELVN) Misses Q2 EPS by 49c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: ELVN) | Delayed: 41.52 -0.41 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.93 | 52 Week High | $ | |||
| Open | $41.49 | 52 Week Low | $ | |||
| Day High | $41.64 | P/E | N/A | |||
| Day Low | $40.82 | EPS | $ | |||
| Volume | 2,298,506 | |||||
